Free orbital fat graft to prevent porous polyethylene orbital implant exposure in patients with retinoblastoma

Ophthalmic Plastic and Reconstructive Surgery

Volumn 21, Issue 4, 2005, Pages 253-258

  Kim, Nam Ju ^a   Choung, Ho Kyung ^a   Khwarg, Sang In ^a   Yu, Young Suk ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

POLYETHYLENE;

ARTICLE; CHILD; CLINICAL ARTICLE; ENUCLEATION; FEMALE; FREE TISSUE GRAFT; HUMAN; IMPLANTATION; MALE; ORBIT IMPLANT; PRIORITY JOURNAL; RETINOBLASTOMA; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR VOLUME;

ADIPOSE TISSUE; BIOCOMPATIBLE MATERIALS; CHILD; CHILD, PRESCHOOL; EYE ENUCLEATION; FEMALE; FOREIGN-BODY MIGRATION; HUMANS; INFANT; MALE; ORBIT; ORBITAL IMPLANTS; POLYETHYLENES; POROSITY; POSTOPERATIVE COMPLICATIONS; PROSTHESIS IMPLANTATION; RETINAL NEOPLASMS; RETINOBLASTOMA;

EID: 23244453666     PISSN: 07409303     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.iop.0000170406.09927.c4     Document Type: Article

References (28)

1. Dutton JJ. Coralline hydroxyapatite as an ocular implant. Ophthalmology 1991;98:370-7.
2. Karesh JW, Dresner SC. High-density porous polyethylene (Medpor®) as a successful anophthalmic socket implant. Ophthalmology 1994;101:1688-96.
3. Rubin LR Polyethylene as a bone and cartilage substitute: a 32-year retrospective. In: Rubin LR, ed. Biomaterials in Reconstructive Surgery. St. Louis: CV Mosby; 1983: chap 30.
4. Buettner HB, Bartley GB. Tissue breakdown and exposure associated with orbital hydroxyapatite implants. Am J Ophthalmol 1992;113:669-73.
5. Remulla HD, Rubin PA, Shore JW, et al. Complications of porous spherical orbital implants. Ophthalmology 1995;102:586-93.
6. Christmas NJ, Gordon CD, Murray TG, et al. Intraorbital Implants after enucleation and their complications. Arch Ophthalmol 1998; 116:1199-203.
7. Nunery WR, Heinz GW, Bonnin JM, et al. Exposure rate of hydroxyapatite spheres in the anophthalmic socket: histopathologic correlation and comparison with silicone sphere implants. Ophthal Plast Reconstr Surg 1993;9(2):96-104.
8. Oestreicher JH, Liu E, Berkowitz M. Complications of hydroxyapatite orbital implants. A review of 100 consecutive cases and a comparison of Dexon mesh (polyglycolic acid) with scleral wrapping. Ophthalmology 1997;104:324-9.
9. Karcioglu ZA, Al-Mesfer SA, Mullaney PB, et al. Porous polyethylene orbital implant in patients with retinoblastoma. Ophthalmology 1998;105:1311-6.
10. Lee V, Subak-Sharpe I, Hungerford JL, et al. Exposure of primary orbital implants in postenucleation retinoblastoma patients. Ophthalmology 2000;107:940-6.
11. Kim JH, Khwarg SI, Choung HK, Yu YS. Management of porous polyethylene implant exposure in patients with retinoblastoma following enucleation. Ophthalmic Surg Lasers Imaging 2004;35: 446-52.
12. Levine MR. Extruding orbital implant: prevention and treatment. Ann Ophthalmol 1980;12:1384-6.
13. Dryden R, Leibsohn J. Postenucleation orbital implant extrusion. Arch Ophthalmol 1978;96:2064-5.
14. Goldberg RA, Holds JB, Ebrahimpour J. Exposed hydroxyapatite orbital implants: reports of six cases. Ophthalmology 1992;99: 831-6.
15. De Potter P, Shields CL, JA, et al. Use of the hydroxyapatite ocular implant in the pediatric population. Arch Ophthalmol 1994;112:208-12.
16. Li T, Shen J, Duffy MT. Exposure rates of wrapped and unwrapped orbital implants following enucleation. Ophthal Plast Reconstr Surg 2001;17:431-5.
17. Iordanidou V, De Potter, P. Porous polyethylene orbital implant in the pediatric population. Am J Ophthalmol 2004;138:425-9.
18. Baylis H, Shorr N. Correction of problems of the anophthalmic socket. In: McCord CD Jr., ed. Oculoplastic surgery. New York: Raven press; 1981: chap. 16.
19. Levine MR. Extruding orbital implant: prevention and treatment. Ann Ophthalmol 1980;12:1384-6.
20. Wiggs EO, Becker BB. Extrusion of enucleation implants: treatment with secondary implants and autogenous temporalis fascia or fascia lata patch grafts. Ophthalmic Surg 1992;23:472-6.
21. Kim YD, Goldberg RA, Shorr N, et al. Management of exposed hydroxyapatite orbital implants. Ophthalmology 1994;101:1709-15.
22. Beaver HA, Patrinely JR, Holds JB, et al. Periocular autografts in socket reconstruction. Ophthalmology 1996;103:1498-502.
23. Salour H, Owji N, Farahi A. Two-stage procedure for management of large exposure defects of hydroxyapatite orbital implant. Eur J Ophthalmol 2003;13:789-93.
24. Drommer RB, Mende U. Free fat transplantation in the face. J Craniomaxillofac Surg 1995;23:228-32.
25. Ghobadi F, Zangeneh M, Massoud BJ. Free fat autotransplantation for the cosmetic treatment of first web space atrophy. Ann Plast Surg 1995;35:197-200.
26. Ullmann Y, Shoshani O, Fodor L, et al. Long-term fat preservation. J Drugs Dermatol 2004;3:266-9.
27. Serra-Renom JM, Fontdevila J. Treatment of facial fat atrophy related to treatment with protease inhibitors by autologous fat injection in patients with human immunodeficiency virus infection. Plast Reconstr Surg 2004;114:551-5.
28. Schuller-Petrovic S. Improving the aesthetic aspect of soft tissue defects on the face using autologous fat transplantation. Facial Plast Surg 1997;13:119-24.